semaglutide and cardiovascular New Science Suggests Improves CV Outcomes Beyond Weight Loss Semaglutide dose may matter more

insulin lispro The SURPASS-6 trial included 1,428 adults with type 2 diabetes inadequately controlled by basal insulin, comparing once-weekly tirzepatide (5 mg, 10 mg, 15 mg) with thrice-daily insulin lispro

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products

Most claims focus on diagnosed gastrointestinal conditions such as gastroparesis (stomach paralysis), ileus, or obstruction-like symptoms that led to emergency care, hospitalization, or long-term specialist follow-up

Individuals without metabolic syndrome typically achieve 2-4 percentage points higher weight loss than those meeting multiple metabolic syndrome criteria

Add Parade as a Preferred Source by clicking here.